End-of-day quote
Shanghai S.E.
23:00:00 02/07/2024 BST
5-day change
1st Jan Change
21.86
CNY
-2.28%
-7.72%
-37.11%
HOB Biotech Group Corp.,Ltd's Equity Buyback announced on March 11, 2024, has closed with 801,314 shares, representing 1.27% for CNY 20 million.
The company closed its plan on May 20, 2024.
Tranche Update on HOB Biotech Group Corp.,Ltd's Equity Buyback Plan announced on March 11, 2024.
05-21
CI
HOB Biotech Group Corp.,Ltd's Equity Buyback announced on March 11, 2024, has closed with 801,314 shares, representing 1.27% for CNY 20 million.
05-19
CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
04-28
CI
HOB Biotech Group Corp.,Ltd announces an Equity Buyback for CNY 30 million worth of its shares.
03-11
CI
HOB Biotech Group Corp.,Ltd authorizes a Buyback Plan.
03-07
CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
02-02
CI
Certain A Shares of HOB Biotech Group Corp., Ltd are subject to a Lock-Up Agreement Ending on 14-JAN-2024.
01-13
CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
26/10/23
CI
HOB Biotech Inks Deal With Spain’s Inmunotek to Distribute Allergy Treatment in China
06/09/23
MT
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
24/08/23
CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
27/04/23
CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
27/02/23
CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
30/10/22
CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
24/08/22
CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
27/04/22
CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
25/02/22
CI
HOB Biotech Group Corp.,Ltd(SHSE:688656) added to Shanghai Stock Exchange Composite Index
21/01/22
CI
HOB Biotech Group Corp.,Ltd(SHSE:688656) added to Shanghai Stock Exchange A Share Index
21/01/22
CI
Certain A Shares of HOB Biotech Group Corp., Ltd are subject to a Lock-Up Agreement Ending on 14-JAN-2022.
13/01/22
CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
20/10/21
CI
Hob Biotech Group Corp.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021
18/08/21
CI
Hob Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021
21/04/21
CI
HOB Biotech Group Corp., Ltd Reports Earnings Results for the Full Year Ended December 31, 2020
14/04/21
CI
HOB Biotech : Surges 112% in Shanghai Trading Debut
14/01/21
MT
Hob Biotech Group Corp., Ltd Reports Earnings Results for the Full Year Ended December 31, 2019
07/01/21
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
HOB Biotech Group Corp Ltd is a China-based company primarily engaged in the research and development, production and sales of in vitro diagnostic reagents. The Company provides two categories of products: allergy testing products and self-immune testing products. Its detection techniques include qualitative detection techniques such as enzyme-linked immunosorbent assay, and quantitative detection techniques such as enzyme-linked immunoassay capture method and nano-magnetic particle chemiluminescence method. The brands of allergy testing products include Oboke, Fubok, Shibok and Shibok Plus. The self-immune testing product brands include Norbok and Nabok. It is also engaged in the provision of reagent supporting testing instruments and others. The Company conducts its businesses in the domestic market.
More about the company
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1